Education
About Us
Working with TipRanks
Follow Us
Holger Weis Insider Profile
4 Followers
Holger Weis, CEO, Director at Alaunos Therapeutics, holds 10.78K shares in Jupiter Neurosciences, Inc. (Ticker: JUNS), holds 181.61K shares in Alaunos Therapeutics (Ticker: TCRT).
Holger Weis has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Holger Weis holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 03, 2021 - Sep 03, 2022
Return:+75.70%
The most profitable trade made by Holger Weis
Holger Weis's Trading History
Alaunos Therapeutics
Jun 24, 2022
CEO, Director
Uninformative Buy
―
$509.95K
Jupiter Neurosciences, Inc.
Jan 24, 2025
Director
Uninformative Buy
38.60K
$17.47K
List of latest transactions for each holding click on a transaction to see Holger Weis's performance on stock
You May Also Like
Holger Weis insider profile FAQ
What is the percentage of profitable transactions made by Holger Weis?
The percentage of profitable transactions made by Holger Weis is ―.
What is the average return per transaction made by Holger Weis?
The average return per transaction made by Holger Weis is ―.
What stocks does Holger Weis hold?
Holger Weis holds: TCRT, JUNS stocks.
What was Holger Weis’s latest transaction?
Holger Weis latest transaction was an Uninformative Buy of $38.60K.
What was Holger Weis's most profitable transaction?
Holger Weis’s most profitable transaction was an Informative Buy of TCRT stock on September 3, 2021. The return on the trade was 75.70%.
What is Holger Weis's role in Alaunos Therapeutics?
Holger Weis's role in Alaunos Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.